Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-12-22
1990-03-27
Henderson, Christopher
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514334, C07D40112, C07D40114
Patent
active
049121189
ABSTRACT:
Compounds in which two or more rings, being a 3-hydroxpypyrid-2-one, 3-hydroypyrid-4-one or 1-hydropyrid-2-one, are linked are of value in the treatment of patients having a toxic concentration of a metal, particularly iron, in the body while the iron complexes of such compounds are of value in the treatment of iron deficien
REFERENCES:
patent: 2429096 (1947-10-01), Ladd et al.
patent: 2686786 (1954-08-01), Shaw et al.
patent: 2742476 (1956-04-01), Bernstein et al.
patent: 2748142 (1956-05-01), Clauson-Kass
patent: 3269904 (1966-08-01), Bernstein
patent: 3419570 (1968-12-01), Brammer
patent: 3705943 (1972-12-01), Kaufman
patent: 3810752 (1974-05-01), Wilcox et al.
patent: 3847927 (1974-11-01), Dunbar
patent: 3864334 (1975-02-01), Pallos
patent: 3928616 (1975-12-01), Pallos
patent: 3963729 (1976-06-01), Gittas
patent: 3968118 (1976-07-01), Lohaus
patent: 4063927 (1977-12-01), Otten et al.
patent: 4143131 (1979-03-01), Lindenbaum
patent: 4181654 (1980-01-01), Weitl
patent: 4293542 (1981-10-01), Lang et al.
patent: 4309305 (1982-01-01), Weitl et al.
patent: 4358455 (1982-11-01), Atkinson et al.
patent: 4396766 (1983-08-01), Farmer, Jr. et al.
patent: 4397867 (1983-08-01), Blake
patent: 4419365 (1983-12-01), McLachlan
patent: 4442305 (1984-04-01), Weitl
patent: 4530963 (1985-07-01), DeVoe et al.
patent: 4543213 (1985-09-01), Weitl
patent: 4585780 (1986-04-01), Hider
patent: 4698431 (1987-10-01), Raymond et al.
Itoh et al., "The Journal of Antibiotics", XXXII, No. 11, pp. 1089-1095, (Nov. 1979).
Barker et al., Chemical Abstracts, vol. 92, No. 21, May 26, 1980, p. 476, Abstract No. 179021g and Journal of Antibiotics, vol. 32, No. 11, 1979.
McInnes et al., Journal of the Chemical Society, Chemical Communications, 1974, No. 8, 218-282.
Neilands, Science, 1967, 156, 1443-1447.
Dittmar et al., 1974, 17, 753-756.
Durbin, P. W. et al., "Kinetics of Plutonium Deposition in the Mouse", Ann. Rpt. 1983-4, Biology and Medicine Division, Lawrence Berkeley Lab. (Apr. 1985).
Durbin, P. W. et al., "New Sequestering Agents for the Actinides . . . ", Ann Rpt. 1983-4, Biology and Medicine Division, Lawrence Bereley Lab., (Apr. 1985).
Raymond, K. N., "Specific Sequestering Agents for Iron and Actinides", in Environmental Inorganic Chemistry, (VCH Publishers, Inc. 1985).
Riley, P. E. et al., "Specific Sequestering Agents for the Actinides, 9, Synthesis of Metal Complexes of 1-Hydroxy-2-Pyridinone . . .", Inorganic Chemistry, 22 (1983), p. 3940 et seq.
Scarrow, R. C. et al., "Ferric Ion Sequesting Agents . . .", Inorganic Chemistry, 24, (1985), p. 954 et seq.
Scarrow et al., CA 102:124493g.
Raymond et al., CA 103:192911n, European Search Report.
Chemical Abstracts, vol. 93, No. 13, 29 Sep. 1980, pate 504, col. 2, Abstract No. 130476r is an abstract of ref. 1 above, Itoh et al.
WPIL Print out re: U.S. Pat. No. 4,587,240.
Chemical Abstracts, vol. 93, No. 13, 09/29/1980, p. 504, col. 2, Abstract No. 130476r.
Chemical Abstracts, vol. 64, No. 3, 01/31/1966, col. 3504.
Pitt et al., "The Design and Synthesis of Chelating Agents for the Treatment of Iron Overload in Colley's Anemia", Research Triangle Institute, DHEW. . . .
Tamhina et al., "Extraction and Spectrophotometric Determination of Iron (III) by 1-Phenyl-2-Methyl-3-Hydroxy-4-Pyridone", Croatica Chemica Acta CCACAA 45. . . .
Berson et al., "Spectra as a Guide to Structure in the Hydroxypyrone and Hydroxypyridone Series", Dept. of Chemistry, University of Southern. . . .
Jacobs, "Screening for Iron Chelating Drugs", Elsevier North Holland, Inc., 1981, pp. 39-46, This publication discusses various drugs useful for iron. . . .
Wilson et al., "Chelation and Biologic Action, Textbook of Organic Medicinal and Pharmaceutical Chemistry", Third Edition, J. B. Lippincott Company. . . .
CA 90:186151m, This document discloses 6-substituted 3-hydroxy-1-methyl-4-pyridones.
CA: 90:167745s, This document discloses 5-hydroxy-2-(hydroxymethyl)-4-pyridones.
CA 89:37739m, This document discusses the comparative toxicities of mimosine and some chemically related compounds, including 3-hydroxy-4-(1H)-pyridone.
CA 86:167059p, This document discloses the inhibition of copper-containing enzymes by L-mimosine, discussing the effect of Fe.sup.3+ or Cu.sup.2+ on this process.
CA 85:104644j, This document discloses the inhibition of wool folicle DNA synthesis by minosine and related 4(1H)-pyridones.
CA 80:103826e, This document discloses aromatic amino acid hydroxylase inhibitors repaired by oxidation of kojic acid benzylether to the pyrone. . . .
CA 77:122732a, This document discloses that mimosinamine dihydrochloride results in complete loss of hair of suckling mice, and that this effect. . . .
J. Med. Chem., (1974), vol. 17, No. 1, pp. 1-5, "Aromatic Acid Hydroxylase Inhibitors . . . ".
CA 86:12119e, This document discloses the synthesis of some 4-pyranones and 4-pyridones.
Bull. Chem. Soc. Japan, 52, No. 1, Jan. 1979, p. 107, K. Imafuku et al., This document discloses the preparation of 5-hydroxy-2-hydroxymethyl-4-pyridone. . . .
CA 85:143377u, This document discusses the formation of pyridone derivatives from maltose and lactose.
Z. Lebensm. Unters. Forsch., T. Severin et al., 1976, This document discloses formation of pyridone derivatives from maltose and lactose.
CA 76:71652u, This document discusses the orientation of the aminomethylation of 2,5-dihydroxypyridine and N-methyl-3-hydroxy-2-pyridone.
J. Med. Chem., (1979), vol. 22, No. 1, This document discloses aromatic amino acid hydroxylase inhibitors which are azadopamine analogs.
CA 74:23102b, This document discloses the synthesis of N-substituted-3-glucosyloxy-2-methyl-4-pyridones and their aglycones.
CA 97:92048a, This document discloses the synthesis and structure of heterocyclic compounds with chelating properties, including maltol.
Bull. Chem. Soc. Japan, 52, No. 1, Jan. 1979, p. 111, K. Imafuku et al., This document discloses the preparation of various 6-substituted 3-. . . .
Inorg. Chem. (1985), 24, pp. 954-967, This paper investigates a range of liganda and identifies the 3-hydroxypyrid-4-ones as being of particular. . . .
J. Chem. Soc., Dalton Trans., (1982), pp. 1433-1438, This paper relates to the iron complexes of two pyridine derivatives, one of which, 2,3-. . . .
The Lancet (Jun. 6, 1987), pp. 1294-1295, This paper illustrates the value of 3-hydroxy-1,2-dimethylpyrid-4-one.
Porter et al., "The Relationship Between . . . ", This paper relates to the value of hydroxypyrid-4-one iron chelators in the treatment of iron overload.
Gyparaki et al., "In Vivo Evaluation of . . . ", This paper relates to the value of a hydroxypyrid-4-one iron chelators in the treatment of treatment of iron. . . .
Bol. Soc. Chil. Quim., 1982, p. 27, 122, This document discloses certain N-alkyl-3-hydroxypyrid-4-one, These are described in the context of their. . . .
Chem. Pharm. Bull., 1980, 28, pp. 28, 2570-2579, This paper describes tests on certain hydroxypyridones which are substituted by an alkyl group at a. . . .
Aust. J. Bol. Sci., 1978, 31, p. 115, This paper describes test for cytotoxic activity on various hydroxypyridones.
Can. J. Chem., 1976, 54, p. 3377, This paper refers to the testing of various compounds, including a N-substituted hydroxypyridone containing. . . .
Pitt et al., "The Design and Synthesis . . . ", Research Triangle Institute, Research Triangle Park, N.C., (1975), this paper provides a. . . .
Aust. J. Bol. Sci., 9176, 29, p. 189, This paper relates to studies on certain metal-free hydroxypyridones as inhibitors of wool folical DNA. . . .
Croatica Chemia Acta CCACAA, 1973, 45, p. 603, This paper is concerned with the use of a hydroxypyridone N-substituted by an aromatic group in. . . .
Yakugaku Zasshi, 1970, 90, p. 1222, This document discloses the synthesis of N-substituted 3-glucosyloxo-2-methyl-4-pyridones, This aglycones, . . . .
J. Bacteriol., (1973), 141 (1), 164-168), This document relates to a variety of compounds, including hydroxypyridones which are siderophores for the . . .
Recueil (1950), pp. 1041-1047, this document describes the preparation of various N-alkyl-3-hydroxypyrid-4-ones, such as the
Hider Robert C.
Kontoghiorghes George
Silver Jack
Stockham Michael A.
Henderson Christopher
National Research Development Corporation
LandOfFree
Pharmaceutical compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1651304